Researchers are fine-tuning immunotherapy to the point where it may soon be able to sic cancer patients’ T-cells only on cellular mutations that matter to the cancer’s survival. The idea is to save the T-cells’ limited energy so the body’s own cancer killers can complete the job without spilling a dangerous drop of their shape-shifter quarries' lifeblood. 

The FDA has issued a new draft guidance intended to assist FDA staff and those in the healthcare industry with submitting investigational device exemption (IDE) applications to conduct clinical trials for neurological medical devices. 

Brainlab, a medical technology company headquartered in Munich, Germany, announced today that its ExTrac Image Guided Radiotherapy treatment was successful in shielding risk organs from toxicity as part of a study investigating the safety and efficacy of stereotactic body radiation therapy (SBRT) in prostate cancer treatment.

Once inside a pregnant woman’s bloodstream, the Zika virus appears capable of afflicting her developing baby not just with micocephaly, as feared and widely speculated, but also with other congenital abnormalities and harsh effects, including injury to the central nervous system and death, according to a study published online March 4 in the New England Journal of Medicine.

With the Major League Baseball season beginning in less than a month, and Spring Training already well underway, baseball is on the minds of a lot of people this time of year. One of the sport’s ongoing problems has long been the health of its pitchers, who throw so frequently with so much velocity that they often end up needing serious corrective surgeries before they even graduate high school. 

A new concussion assessment tool could improve doctors’ ability to determine whether pediatric patients will experience persistent post-concussive symptoms (PPCS), according to results of a new study published online March 8 in JAMA.

Elekta, the Stokholm, Sweden-based supplier of radiation oncology and neurosurgery systems, announced today that its Leksell Gamma Knife Icon stereotactic radiosurgery system (SRS) was used to treat a patient in the United States for the first time.

Mass thyroid screenings of children at risk of cancer from the 2011 meltdown at Fukushima handed Japanese health officials what they most feared finding—lots of abnormalities. And now the program has set off a firestorm of fear and criticism.